[PLX] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
07-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 717.66%
YoY- 475.95%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 13,474 35,075 8,753 6,427 10,967 12,247 2,006 37.32%
PBT -2,272 19,647 -5,334 -11,241 -4,150 -7,743 -11,294 -23.43%
Tax -69 308 -190 128 38 3 75 -
NP -2,203 19,339 -5,144 -11,241 -4,150 -7,743 -11,294 -23.82%
Tax Rate - -1.57% - - - - - -
Total Cost 15,677 15,736 13,897 17,668 15,117 19,990 13,300 2.77%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -16.35 55.14 -58.77 -174.90 -37.84 -63.22 -563.01 -44.52%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.03 0.29 -0.11 -0.25 -0.13 -0.52 -0.77 -41.74%
EPS Diluted -0.03 0.21 -0.11 -0.25 -0.13 -0.52 -0.77 -41.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.